Researchers from Denmark and the United States have discovered an effective nonestrogen treatment for osteoporosis in postmenopausal women.
In February's Journal of Clinical Endocrinology and Metabolism, the researchers report on a study of 111 healthy, early postmenopausal women with normal bone mass who were randomized to receive risedronate bisphosphonate or a placebo for 2 years. The effect on bone mass was determined by measuring bone mineral density and levels of biochemical bone markers in the blood and urine.
Voelker R. New Osteoporosis Treatment. JAMA. 1998;279(14):1058. doi:10.1001/jama.279.14.1058-JWM80001-6-1